blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1071660

EP1071660 - N-SULPHONYL AND N-SULPHINYL PHENYLGLYCINAMIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.11.2003
Database last updated on 05.10.2024
Most recent event   Tooltip22.12.2006Lapse of the patent in a contracting state
New state(s): IE
published on 24.01.2007  [2007/04]
Applicant(s)For all designated states
Syngenta Participations AG
Schwarzwaldallee 215
4058 Basel / CH
[2001/13]
Former [2001/05]For:BE  CH  DE  DK  ES  FI  FR  GB  GR  IE  IT  LU  MC  NL  PT  SE  CY  LI 
Novartis AG
Schwarzwaldallee 215
4058 Basel / CH
For:AT 
Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
Brunner Strasse 59
1235 Wien / AT
Inventor(s)01 / JEANGUENAT, André
Birsigstrasse 81
CH-4054 Basel / CH
02 / ZELLER, Martin
Kronengasse 7
CH-5400 Baden / CH
 [2001/05]
Application number, filing date99911707.025.02.1999
[2001/05]
WO1999EP01216
Priority number, dateGB1998000426527.02.1998         Original published format: GB 9804265
[2001/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9943644
Date:02.09.1999
Language:EN
[1999/35]
Type: A1 Application with search report 
No.:EP1071660
Date:31.01.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.1999 takes the place of the publication of the European patent application.
[2001/05]
Type: B1 Patent specification 
No.:EP1071660
Date:22.01.2003
Language:EN
[2003/04]
Search report(s)International search report - published on:EP02.09.1999
ClassificationIPC:C07C307/06, C07C311/06, A01N41/06
[2001/05]
CPC:
A01N41/02 (EP,US); C07C307/06 (EP,KR,US); A01N41/06 (EP,US);
C07C237/08 (EP,US); C07C311/06 (EP,US); C07C323/63 (EP,US);
C07D307/54 (EP,US); C07D333/24 (EP,US); C07D333/28 (EP,US);
C07C2603/18 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/05]
TitleGerman:N-SULPHONYL UND N-SULPHINYL PHENYLGLYCINAMIDE[2001/05]
English:N-SULPHONYL AND N-SULPHINYL PHENYLGLYCINAMIDE[2001/05]
French:N-SULFONYL ET N-SULFINYL PHENYLGLYCINAMIDE[2001/05]
Entry into regional phase31.07.2000National basic fee paid 
31.07.2000Designation fee(s) paid 
31.07.2000Examination fee paid 
Examination procedure30.08.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.07.2000Examination requested  [2001/05]
23.03.2001Despatch of a communication from the examining division (Time limit: M04)
07.07.2001Reply to a communication from the examining division
23.04.2002Despatch of communication of intention to grant (Approval: Yes)
13.08.2002Communication of intention to grant the patent
23.10.2002Fee for grant paid
23.10.2002Fee for publishing/printing paid
Opposition(s)23.10.2003No opposition filed within time limit [2004/03]
Fees paidRenewal fee
11.01.2001Renewal fee patent year 03
16.01.2002Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.01.2003
BE22.01.2003
FI22.01.2003
GR22.01.2003
CY25.02.2003
IE25.02.2003
LU25.02.2003
MC28.02.2003
DK22.04.2003
PT22.04.2003
SE22.04.2003
[2007/04]
Former [2005/02]AT22.01.2003
BE22.01.2003
FI22.01.2003
GR22.01.2003
CY25.02.2003
LU25.02.2003
MC28.02.2003
DK22.04.2003
PT22.04.2003
SE22.04.2003
Former [2004/44]AT22.01.2003
BE22.01.2003
FI22.01.2003
GR22.01.2003
CY25.02.2003
LU25.02.2003
DK22.04.2003
PT22.04.2003
SE22.04.2003
Former [2004/39]AT22.01.2003
BE22.01.2003
FI22.01.2003
GR22.01.2003
LU25.02.2003
DK22.04.2003
PT22.04.2003
SE22.04.2003
Former [2004/10]AT22.01.2003
BE22.01.2003
FI22.01.2003
GR22.01.2003
DK22.04.2003
PT22.04.2003
SE22.04.2003
Former [2004/02]AT22.01.2003
FI22.01.2003
GR22.01.2003
DK22.04.2003
PT22.04.2003
SE22.04.2003
Former [2003/47]AT22.01.2003
FI22.01.2003
GR22.01.2003
PT22.04.2003
SE22.04.2003
Former [2003/46]FI22.01.2003
GR22.01.2003
PT22.04.2003
SE22.04.2003
Former [2003/43]FI22.01.2003
PT22.04.2003
SE22.04.2003
Former [2003/41]FI22.01.2003
SE22.04.2003
Former [2003/30]SE22.04.2003
Cited inInternational search[DA]EP0493683  (AMERICAN CYANAMID CO [US]) [DA] 1-12 * examples 5,52 *;
 [A]WO9530651  (CIBA GEIGY AG [CH]) [A] 1-12;
 [PX]WO9838160  (CIBA GEIGY AG [CH], et al) [PX] 1-12* claims 1,7,8 *;
 [X]  - CLARK, C.R. ET AL., "Diastereoisomeric Derivatization and Liquid Chromatographic Analysis of N-(Phenylsulfonyl)-2-phenylglycine Aldose Reductase Inhibitors", JOURNAL OF CHROMATOGRAPHIC SCIENCE, (199008), vol. 28, no. 8, pages 407 - 412, XP002106164 [X] 1 * table II *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.